小剂量喹硫平联合齐拉西酮对女性精神分裂症患者的疗效及体质量、血清泌乳素水平的变化观察

Small dose quetiapine flat joint ziprasidone for women the curative effect of patients with schizophrenia and body quality, the change of serum prolactin level observation

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2017, 44(4)
作者
作者单位

常熟市第三人民医院,精神科 ;
山东省精神卫生中心精神科 ;

摘要
【摘要】目的:研究小剂量喹硫平联合齐拉西酮对女性精神分裂症患者的疗效及体质量、血清泌乳素水平作用效果。方法:选取2014年6月至2016年7月在我院接受治疗的精神分裂症女性患者84例,随机分为观察组及对照组,每组各42例。对照组患者给予齐拉西酮治疗,观察组则给予小剂量喹硫平联合齐拉西酮治疗,对比治疗前后阳性与阴性症状量表(PANSS)、临床整体印象量表(CGI)、不良反应症状量表(TESS)变化以及。结果:观察组治疗总有效率为92.86%(39/42),显著高于对照组的76.19%(32/42),差异有统计学意义(P<0.05)。治疗后两组PANSS评分及CGI评分均显著低于治疗前,而观察组又显著低于对照组,差异均有统计学意义(均P<0.05)。治疗前两组TESS评分均无统计学差异,治疗后两组TESS评分均无统计学差异无统计学意义(均P>0.05)。治疗前后两组体质量对比无显著差异,治疗后观察泌乳素显著低于对照组,差异均有统计学意义(均P<0.05)。治疗前两组体质量、泌乳素比较无显著差异(均P>0.05),治疗后两组患者体质量、泌乳素较治疗前显著升高(P<0.05),两组体质量、泌乳素比较无统计学差异(均P>0.05)。结论:小剂量喹硫平联合齐拉西酮治疗女性精神分裂症在提高临床疗效显著,但其可致血清泌乳素和体质量增高,应给予有效干预,避免泌乳素升高。
Abstract
【Abstract】 Objective: To study the small dose quetiapine flat joint ziprasidone for women the curative effect of patients with schizophrenia and body quality, serum prolactin level effect. Methods: From June 2014 to July 2016, 84 patients with schizophrenia in our hospital were randomly divided into observation group and control group, 42 cases in each group. The control group were treated with ziprasidone treatment, the observation group was treated with a small dose of quetiapine combined with ziprasidone treatment, compared before and after treatment of positive and negative symptom scale (PANSS), Clinical Global Impression Scale (CGI) and Treatment Emergent Symptom Scale (TESS) and the changes of. Results: the total effective rate of the observation group was 92.86% (39/42), significantly higher than that of the control group (32/42), the difference was statistically significant (P < 0.05). After treatment, the two groups of PANSS score and CGI score were significantly lower than before treatment, while the observation group was significantly lower than the control group, the differences were statistically significant (both P < 0.05). There was no significant difference in TESS scores between the two groups before treatment, and there was no significant difference in TESS scores between the two groups after treatment (mean P>0.05). There was no significant difference in the two groups before and after treatment, and the difference was statistically significant (both P < 0.05), the difference was statistically significant after treatment. The two groups before treatment, body weight and prolactin were no significant difference (P>0.05), body weight, lactation after treatment two groups of patients were significantly higher than those before treatment (P<0.05), two groups of body weight and prolactin had no significant difference (P>0.05). Conclusion: A small dose of quetiapine combined with ziprasidone in the treatment of female schizophrenia in improving the clinical curative effect, but it can cause serum prolactin and body weight increased, should give effective intervention to avoid elevated prolactin.
关键词
【关键词】喹硫平;齐拉西酮;精神分裂症;疗效;泌乳素
KeyWord
【 Key words 】 quetiapine flat; Ziprasidone; Schizophrenia; Curative effect; prolactin
基金项目
页码 605-607
  • 参考文献
  • 相关文献
  • 引用本文

杨力*,王盟,顾冬云,沈洁. 小剂量喹硫平联合齐拉西酮对女性精神分裂症患者的疗效及体质量、血清泌乳素水平的变化观察 [J]. 国际精神病学杂志. 2017; 44; (4). 605 - 607.

  • 文献评论

相关学者

相关机构